Cite
Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry.
MLA
Pedrazzoli, Paolo, et al. “Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry.” Biology of Blood & Marrow Transplantation, vol. 20, no. 4, Apr. 2014, pp. 501–06. EBSCOhost, https://doi.org/10.1016/j.bbmt.2013.12.569.
APA
Pedrazzoli, P., Martinelli, G., Gianni, A. M., Da Prada, G. A., Ballestrero, A., Rosti, G., Frassineti, G. L., Aieta, M., Secondino, S., Cinieri, S., Fedele, R., Bengala, C., Bregni, M., Grasso, D., De Giorgi, U., Lanza, F., Castagna, L., Bruno, B., & Martino, M. (2014). Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry. Biology of Blood & Marrow Transplantation, 20(4), 501–506. https://doi.org/10.1016/j.bbmt.2013.12.569
Chicago
Pedrazzoli, Paolo, Giovanni Martinelli, Alessandro Massimo Gianni, Gian Antonio Da Prada, Alberto Ballestrero, Giovanni Rosti, Giovanni Luca Frassineti, et al. 2014. “Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry.” Biology of Blood & Marrow Transplantation 20 (4): 501–6. doi:10.1016/j.bbmt.2013.12.569.